Skip to content
Med Pharma News

Med Pharma News

Your Daily Dose of Pharma News

  • About Med Pharma News
  • Contact Us
  • News
  • Privacy Policy
  • Terms and Conditions
  • Home
  • OLN324

Tag: OLN324

J&J Ollin acquisition OLN324 deal infographic
  • Industry Insights

J&J Ollin Acquisition: $2.2B Bet on an Eye Drug Built to Beat Vabysmo

Megan Wood11 minutes ago11 minutes ago09 mins

J&J will pay $2.2B upfront for Ollin Biosciences and its VEGF/Ang2 eye drug OLN324, with Blackstone funding $750M of Phase 3. Terms, science and risks.

Read More

Categories

  • Healthcare IT (26)
  • Industry Insights (351)
  • Lifestyle and Wellness (24)
  • Medical Devices (45)
  • Pharmaceuticals (105)
  • Uncategorized (1)

Recent Posts

  • J&J Ollin Acquisition: $2.2B Bet on an Eye Drug Built to Beat Vabysmo
  • CagriSema Weight Loss: Early Responders Lose 25% in New REDEFINE 1 Analysis
  • Lilly ObesityWeek 2026 Data: EloraTZP Hits 23% Weight Loss, Retatrutide Tackles Sleep Apnea
  • Heidi Overton FDA Vote: One GOP Defection Could Sink the Commissioner Pick
  • Windward Bio IPO: $175M Raise Puts Twice-Yearly Asthma Antibody in the Spotlight
Digital Newspaper - Multipurpose News WordPress Theme 2026. Powered By BlazeThemes.